Evidence map›Paper›PMID 21098703›Full record

ArticleCancer research2010

Homotypic gap junctional communication associated with metastasis suppression increases with PKA activity and is unaffected by PI3K inhibition.

Thomas M Bodenstine, Kedar S Vaidya, Aimen Ismail, Benjamin H Beck, Leah M Cook, Anne R Diers, Aimee Landar, Danny R Welch

Open access · bronzeAbstract read
In one paragraph

Article in Cancer research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Bioscience reports · 2017
    Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Mesenchymal Stromal Cells: Emerging Roles in Bone Metastasis.International journal of molecular sciences · 2018
    Review
  8. Article
  9. IRES inhibition induces terminal differentiation and synchronized death in triple-negative breast cancer and glioblastoma cells.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Analytical methods : advancing methods and applications · 2015
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Thomas M BodenstineDepartment of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Kedar S Vaidya
Aimen Ismail
Benjamin H Beck
Leah M Cook
Anne R Diers
Aimee Landar
Danny R Welch
Cancer Research Center · USUniversity of Alabama at Birmingham · USNational Foundation for Cancer Research · US

Funding

MOLECULAR REGULATION OF BREAST CANCER METASTASISR01CA087728 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI WELCH, DANNY R. · 2000 to 2008
$2.7M
KISS1: Defining Mechanisms for Antimetastatic TherapyR01CA134981 · NCI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI WELCH, DANNY R. · 2009 to 2014
$1.5M
NCI NIH HHS CA134981NCI NIH HHS CA87728NCI NIH HHS R01 CA087728NCI NIH HHS R01 CA134981
6 · The paper itself

Abstract

Loss of gap junctional intercellular communication (GJIC) between cancer cells is a common characteristic of malignant transformation. This communication is mediated by connexin proteins that make up the functional units of gap junctions. Connexins are highly regulated at the protein level and phosphorylation events play a key role in their trafficking and degradation. The metastasis suppressor breast cancer metastasis suppressor 1 (BRMS1) upregulates GJIC and decreases phosphoinositide-3-kinase (PI3K) signaling. On the basis of these observations, we set out to determine whether there was a link between PI3K and GJIC in tumorigenic and metastatic cell lines. Treatment of cells with the well-known PI3K inhibitor LY294002, and its structural analogue LY303511, which does not inhibit PI3K, increased homotypic GJIC; however, we found the effect to be independent of PI3K/AKT inhibition. We show in multiple cancer cell lines of varying metastatic capability that GJIC can be restored without enforced expression of a connexin gene. In addition, while levels of connexin 43 remained unchanged, its relocalization from the cytosol to the plasma membrane was observed. Both LY294002 and LY303511 increased the activity of protein kinase A (PKA). Moreover, PKA blockade by the small molecule inhibitor H89 decreased the LY294002/LY303511-mediated increase in GJIC. Collectively, our findings show a connection between PKA activity and GJIC mediated by PI3K-independent mechanisms of LY294002 and LY303511. Manipulation of these signaling pathways could prove useful for antimetastatic therapy.

Indexed as

Cell CommunicationAndrostadienesCell Line, TumorCell MembraneChromonesConnexin 43Cyclic AMP-Dependent Protein KinasesCytosolEnzyme ActivationEnzyme InhibitorsFluoresceinsFluorescent Antibody TechniqueGap JunctionsHumansImmunoblottingIsoquinolines2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-oneAndrostadienesChromonesConnexin 43Cyclic AMP-Dependent Protein KinasesEnzyme InhibitorsFluoresceinsfluorexonIsoquinolinesLY 303511MorpholinesN-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamidePhosphatidylinositol 3-KinasesPhosphoinositide-3 Kinase InhibitorsPiperazinesProto-Oncogene Proteins c-aktSulfonamidesWortmannin

Identifiers

PMID21098703
PMCPMC3003438
OpenAlexW2145623020

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.